You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Company Profile

GlaxoSmithKline Plc in Consumer Health

Sep 2012

Price: US$525

About this Report

About this Report


Euromonitor International's report on GlaxoSmithKline Plc delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy.

Company and market share data provide a detailed look at the financial position of GlaxoSmithKline Plc, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of GlaxoSmithKline Plc This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWOT analysis of GlaxoSmithKline Plc provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research You Can Trust

Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out.

Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Delivery:
Reports are delivered in pdf format and can be downloaded from your online account (called My Pages) immediately after purchase.

Table of Contents

Table of Contents

Scope of the Report

Scope

Strategic Evaluation

Key company facts

Consumer healthcare a vital supplementary business

Consumer Healthcare delivered static sales performance

SWOT: GlaxoSmithKline Plc

Strategic objectives and challenges

Competitive Positioning

GSK performs in line with global market

Top 10 global players in consumer health

Market Assessment

Core treatment OTC drive organic growth

International markets boost performance

Geographic and Category Opportunities

GSK maintained shares and positions in global OTC

Key brands drive sales in analgesics

Emerging markets lead growth potential in analgesics

Highly successful in Middle East and Africa

NRT smoking cessation aids rebounds in 2011

Antacids strong in Americas

Antacids offer GSK better future in emerging markets

Vitamins and dietary supplements not a key focus in business

Reducing VDS but increasing in sports nutrition

Sports nutrition has strong scope for growth

Fading star of OTC obesity

Bleak outlook for both Alli and the category as a whole

Prioritise growth opportunities in emerging markets

Stepping up investment scope in Asia Pacific

Brand Strategy

Brand portfolio comprehensive, consolidation to improve efficiency

Panadol : Flagship brand with immense growth potential

Emerging markets the key focus for future growth

Tums: Strong performance through devoted product development

Tums: International expansion needed for sustainable growth

Operations

Research and development, production and distribution

Recommendations

Long-term business growth set on emerging markets

Samples

Please update/install flash.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!